Voya Investment Management LLC Sells 276 Shares of Amedisys, Inc. (NASDAQ:AMED)

Voya Investment Management LLC cut its holdings in Amedisys, Inc. (NASDAQ:AMED) by 6.6% during the 4th quarter, according to its most recent Form 13F filing with the Securities and Exchange Commission. The firm owned 3,893 shares of the health services provider’s stock after selling 276 shares during the period. Voya Investment Management LLC’s holdings in Amedisys were worth $353,000 as of its most recent SEC filing.

Other institutional investors and hedge funds have also modified their holdings of the company. Cigogne Management SA purchased a new stake in shares of Amedisys in the 4th quarter worth $2,692,000. Adage Capital Partners GP L.L.C. grew its holdings in Amedisys by 32.3% during the fourth quarter. Adage Capital Partners GP L.L.C. now owns 418,002 shares of the health services provider’s stock valued at $37,950,000 after purchasing an additional 102,099 shares during the period. Price T Rowe Associates Inc. MD increased its position in Amedisys by 9.7% in the fourth quarter. Price T Rowe Associates Inc. MD now owns 18,296 shares of the health services provider’s stock worth $1,662,000 after buying an additional 1,625 shares in the last quarter. Pinebridge Investments L.P. raised its stake in shares of Amedisys by 40.7% in the fourth quarter. Pinebridge Investments L.P. now owns 15,118 shares of the health services provider’s stock worth $1,373,000 after buying an additional 4,374 shares during the period. Finally, Tower Research Capital LLC TRC lifted its position in shares of Amedisys by 66.0% during the 4th quarter. Tower Research Capital LLC TRC now owns 3,512 shares of the health services provider’s stock valued at $319,000 after buying an additional 1,396 shares in the last quarter. Hedge funds and other institutional investors own 94.36% of the company’s stock.

Amedisys Stock Performance

NASDAQ:AMED opened at $95.36 on Monday. The stock has a 50-day moving average price of $92.97 and a 200 day moving average price of $91.65. The stock has a market capitalization of $3.13 billion, a P/E ratio of 37.84, a P/E/G ratio of 1.78 and a beta of 0.96. Amedisys, Inc. has a 12-month low of $82.15 and a 12-month high of $98.95. The company has a current ratio of 1.19, a quick ratio of 1.19 and a debt-to-equity ratio of 0.05.

Amedisys (NASDAQ:AMED) last announced its quarterly earnings data on Wednesday, April 23rd. The health services provider reported $1.25 earnings per share (EPS) for the quarter, beating analysts’ consensus estimates of $1.13 by $0.12. The business had revenue of $594.78 million during the quarter, compared to analyst estimates of $597.43 million. Amedisys had a net margin of 3.57% and a return on equity of 12.20%. The company’s revenue was up 4.1% on a year-over-year basis. During the same period last year, the firm posted $1.03 EPS. Equities research analysts forecast that Amedisys, Inc. will post 4.4 EPS for the current fiscal year.

Wall Street Analyst Weigh In

A number of research firms have commented on AMED. Stephens restated an “equal weight” rating and set a $101.00 target price on shares of Amedisys in a research note on Tuesday, March 4th. Royal Bank of Canada reissued an “outperform” rating and issued a $100.00 price objective on shares of Amedisys in a research note on Wednesday, April 16th. Four investment analysts have rated the stock with a hold rating and one has given a buy rating to the company. Based on data from MarketBeat, the company presently has a consensus rating of “Hold” and an average target price of $100.75.

Amedisys Profile

Amedisys, Inc, together with its subsidiaries, provides healthcare services in the United States. It operates through three segments: Home Health, Hospice, and High Acuity Care. The Home Health segment offers a range of services in the homes of individuals for the recovery of patients from surgery, chronic disability, or terminal illness, as well as prevents avoidable hospital readmissions through its skilled nurses; nursing services, rehabilitation therapists specialized in physical, speech, and occupational therapy; and social workers and aides for assisting its patients.